Last reviewed · How we verify
Indiana Hand to Shoulder Center — Portfolio Competitive Intelligence Brief
2 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Clostridial collagenase injectable | Clostridial collagenase injectable | marketed | ||||
| Injectable clostridial collagenase | Injectable clostridial collagenase | marketed | Collagenase enzyme | Collagen (types I and III) | Orthopedics / Hand Surgery |
Therapeutic area mix
- Orthopedics / Hand Surgery · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Charitable Union for the Research and Education of Peyronie's Disease · 1 shared drug class
- DMR Research, PLLC · 1 shared drug class
- Hospital for Special Surgery, New York · 1 shared drug class
- Luxurgery · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Indiana Hand to Shoulder Center:
- Indiana Hand to Shoulder Center pipeline updates — RSS
- Indiana Hand to Shoulder Center pipeline updates — Atom
- Indiana Hand to Shoulder Center pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Indiana Hand to Shoulder Center — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/indiana-hand-to-shoulder-center. Accessed 2026-05-17.